ProMIS Neurosciences, Inc. announced that it has received $20.483758 million in funding from Affinity Asset Advisors, LLC, Ally Bridge Group, Sphera Healthcare US Inc.

On August 31, 2023, ProMIS Neurosciences, Inc., closed the transaction. The company issued 9,945,969 common share at a price of $1.88 per unit consisting of one common share and one warrant and 954,725 pre-funded units at a price of $1.87 per unit consisting of one pre-funded warrant for the gross proceeds of $20.4 million.